La Rosa Holdings SRTM
La Rosa Holdings: securities offering (amended)
- Form
- S-1/A
- Filed
- Importance
- Routine
- Accession
- 0001575872-23-001439
- Document
- S-1/A
Not explained yet; the original is on EDGAR.
Securities offering (amended)
What changed since the last draft
22 changes since the S-1/A filed Sep 1, 2023
Compared with the S-1/A 0001575872-23-001395, filed Sep 1, 2023.
Shares offered: not stated
Shares offered now not stated; the earlier draft had 1,000,000.
From the filings
Before
We are offering 1,000,000 shares of our Common Stock, $0.0001 par value per share (the "Common Stock" or the "Securities"), in a firm commitment underwritten public offering (this "Offering") at an initial public offering price of $5.00 per share.Exchange: not stated
Exchange now not stated; the earlier draft had Nasdaq Capital Market.
From the filings
Before
Although we are a "controlled company" under the rules of the Nasdaq Capital Market, our board of directors will be composed of a majority of independent directors, and we will not take advantage of the "controlled company" exemptions provided under such rules.Ticker reserved: not stated
Ticker reserved now not stated; the earlier draft had LRHC.
From the filings
Before
Market ("Nasdaq"), under the symbol "LRHC."Controlled company
No longer mentioned in this draft.
From the filings
Before
Although we are a "controlled company" under the rules of the Nasdaq Capital Market, our board of directors will be composed of a majority of independent directors, and we will not take advantage of the "controlled company" exemptions provided under such rules.New section: Exhibits
of Incorporation of La Rosa Holdings Corp.
From the filings
Now
of Incorporation of La Rosa Holdings Corp.Section removed: Prospectus summary
This summary highlights certain information
From the filings
Before
This summary highlights certain informationSection removed: Risk factors
in our Securities involves a high degree of risk and purchasers of our Securities may lose their entire investment.
From the filings
Before
in our Securities involves a high degree of risk and purchasers of our Securities may lose their entire investment. See "Risk Factors" starting on page 17 and the other information included and incorporated by reference into this prospectus for a discussion of risk factors you should carefully consider before deciding to invest in our Securities.Section removed: Forward-looking statements
prospectus contains "forward-looking statements." Forward-looking statements reflect the current view about future events.
From the filings
Before
prospectus contains "forward-looking statements." Forward-looking statements reflect the current view about future events.Section removed: Business
disruptions due to the pandemic may continue, particularly if stringent mitigation actions by government authorities are put in place or remain in place for a significant amount of time.
From the filings
Before
disruptions due to the pandemic may continue, particularly if stringent mitigation actions by government authorities are put in place or remain in place for a significant amount of time. The future impact of the COVID-19 pandemic on our liquidity, financial condition and results of operations is unknown, and its impact may be variable over time as government regulations, market conditions and consumer behavior changes in response to developments with respect to the pandemic.Section removed: Use of proceeds
to us from the sale of the Common Stock offered by us will be approximately $2,485,000 based on an initial public offering price of $5.00 per share and after deducting estimated underwriting discounts and commissions…
From the filings
Before
to us from the sale of the Common Stock offered by us will be approximately $2,485,000 based on an initial public offering price of $5.00 per share and after deducting estimated underwriting discounts and commissions and estimated offering expenses. If the underwriter's option to purchase additional shares of Common Stock in this Offering is exercised in full, we estimate that our net proceeds will be approximately $3,167,500. We will not receive any of the proceeds from the sale of our Common Stock by the Selling Stockholders or the Representative with respect to the Common Stock issuable upon exercise of the Representative's Warrant. However, upon any exercise of the Representative's Warrant, we will receive cash proceeds per share equal to the exercise price of the Representative's Warrant which is $5.50 per share (110% of the public offering price per share). If all 50,000 shares of Common Stock exercisable under the Representative's Warrant are exercised, the aggregate gross proceeds from the exercise of those warrants would be approximately $275,000 (or $316,250 if the Representative exercises the over-allotment option in full).Section removed: Capitalization
our cash and our capitalization as of June 30, 2023:
From the filings
Before
our cash and our capitalization as of June 30, 2023:Section removed: Dilution
you invest in our Common Stock in this Offering, your interest in our Common Stock will be diluted to the extent of the difference between the initial public offering price per share of our Common Stock (calculated for…
From the filings
Before
you invest in our Common Stock in this Offering, your interest in our Common Stock will be diluted to the extent of the difference between the initial public offering price per share of our Common Stock (calculated for purposes of this discussion to be the initial public offering price of one share) and the pro forma as adjusted net tangible book value per share of our Common Stock after this Offering.
and 10 more, in the redline below
Show the redline
Section by section. Added words and removed words against the earlier filing.
Cover page 69 changes
on September 1, 2023.
As filed with the U.S. Securities and Exchange Commission
on September 12, 2023
Registration No. 333-264372
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
LA ROSA HOLDINGS CORP.
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of
4 unchanged paragraphs
1420 Celebration Blvd., 2 nd Floor
Celebration, FL 34747
(Address, including zip code and telephone number, including area code, of agent for service)
including zip code and telephone number, including area code, of registrant's principal executive offices)
Chief Executive Officer
1420 Celebration Blvd., 2 nd Floor
Celebration, FL 34747
(Name, address, including zip code and telephone
number, including area code, of agent for service)
Please send copies of all communications to:
Ross D. Carmel, Esq.
2 unchanged paragraphs
M. Ali Panjwani, Esq.
Approximate date of commencement of proposed sale to the public:
1 unchanged paragraph
any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended (the "Securities Act"), check the following box. ☒ this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer,"
If any of the securities being
registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended (the "Securities Act"), check the following box. x
If this form is filed to register
additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities
Act registration statement number of the earlier effective registration statement for the same offering.
If this form is a post-effective
amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
If this form is a post-effective
amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
1 unchanged paragraph
information in this prospectus is not complete and may be changed. Neither we nor the selling stockholders may sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject to Completion, Dated September 1, 2023
Shares of Common Stock
This is the initial public offering
by La Rosa Holdings Corp., a Nevada corporation (the "Company"). We are offering 1,000,000 shares of our Common Stock, $0.0001 par value per share (the "Common Stock" or the "Securities"), in a firm commitment underwritten public offering (this "Offering") at an initial public offering price of $5.00 per share.
We have also registered for public sale: (i) 50,000 shares of our Common
Stock issuable to the representative of the underwriters ("Representative") upon the exercise of a warrant to be issued to the Representative (or 57,500 shares if the Representative exercises the over-allotment option in full); and (ii) 2,469,840 shares of
Common Stock held by 168 selling stockholders (the Representative and the selling stockholders referred to herein as the "Selling
Stockholders"). We will not receive any of the proceeds from the sale of Common Stock by the Selling Stockholders. However, upon any exercise of the warrant held by the Representative (the "Representative's Warrant"), we will receive cash proceeds per share equal to the exercise price of such warrant. The shares to be sold by the Selling Stockholders (the "Selling
Stockholder Shares") will not be purchased by the underwriters or otherwise included in the underwritten offering of our Common
Stock in this initial public offering. The Selling Stockholders may sell or otherwise dispose of their shares in a number of different ways and at varying prices, but will not sell any Selling Stockholder Shares until after the closing of this Offering. See "Selling
Stockholders-Plan of Distribution." We will pay all expenses (other than discounts, concessions, commissions and similar selling expenses, if any) relating to the registration of the Selling Stockholders' shares of Common Stock with the Securities and Exchange has been no public market our Common Stock prior to this Offering. We have applied to list the Common Stock on the Nasdaq Capital
Market ("Nasdaq"), under the symbol "LRHC."
Following the completion of this
Offering, our Founder, Chairman of the board of directors and Chief Executive Officer, Mr. Joseph La Rosa, will control 83.2% of the total voting power of our voting capital stock with respect to director elections and all other matters. Although we are a "controlled company" under the rules of the Nasdaq Capital Market, our board of directors will be composed of a majority of independent directors, and we will not take advantage of the "controlled company" exemptions provided under such rules. Please see "Security
Ownership of Certain Beneficial Owners and Management."
Investing in our Securities
involves a high degree of risk. See "Risk Factors" beginning on page 17 of this prospectus for a discussion of information that should be considered in connection with an investment in our Securities.
are an "emerging growth company" as that term is used in the Jumpstart Our Business Startups Act of 2012 (the "JOBS
Act") and, as such, we have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings. See "Prospectus Summary - Implications of Being an Emerging Growth Company."
the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.
Non-accelerated filer ☒ x
Smaller reporting company ☒ x
Emerging growth company ☒ x
If an emerging growth company,
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
The Registrant hereby amends this registration
Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, or until this registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.
Act of 1933, or until this registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.
This Amendment No. 13 to the
Registration Statement on Form S-1 (File No. 333-264372) is filed solely to amend Exhibit 5.1 thereto. Accordingly, this Amendment No.
13 consists only of the facing page, this explanatory note, Item 16(a) of Part II of the Registration Statement, the signature page to the Registration Statement, and Exhibit 5.1. The remainder of the Registration Statement is unchanged and has therefore been omitted.
INFORMATION NOT REQUIRED
Only in this filing: Exhibits
Only in the earlier filing: Prospectus summary, Risk factors, Forward-looking statements, Business, Use of proceeds, Capitalization, Dilution, Dividend policy, Market for the common stock, MD&A, Properties, Management, Principal stockholders, Plan of distribution, Notes to the financial statements, Note 1: DESCRIPTION OF BUSINESS AND NATURE OF OPERATIONS, Note 2: SUMMARY OF SIGNIFICANT ACCOUNTING, Note 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued), Note 3: CONCENTRATIONS OF BUSINESS AND CREDIT RISK, Note 4: RELATED PARTY TRANSACTIONS, Note 5: COMMITMENTS AND CONTINGENCIES, Legal proceedings, Note 6: DEBT, Note 6: DEBT (continued), Note 7: EQUITY, Note 7: EQUITY (continued), Note 8: SEGMENTS, Note 5: Real Estate Brokerage Services, Note 8: SEGMENTS (continued), Note 9: INCOME TAXES, Note 10: SUBSEQUENT EVENTS, Financial statements
Compared by code from the two drafts’ text: offering terms first, then sections and risk factors added or removed, numbers that moved, and rewording. No model wrote this list. Not investment advice.
Similar companies
Companies of similar size in SIC 6531 and related industry codes: the same peer list as the financial tables.
- Offerpad Solutions OPAD public float $11M, Jun 30, 2025
- Fathom Holdings FTHM public float $22M, Jun 30, 2025
- RE/MAX Holdings RMAX public float $161M, Jun 30, 2025
- Douglas Elliman DOUG public float $191M, Jun 30, 2025
- Opendoor Technologies OPEN public float $340M, Jun 30, 2025
